West Paces Advisors’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
West Paces Advisors's TWST Position: Q3 2026 in Review
West Paces Advisors reduced its Twist Bioscience (TWST) stake by 19% in Q3 2026, selling an estimated $9.5K and leaving 322 shares worth $62.2K. The position accounts for 0.01% of the portfolio, ranked #265.
West Paces Advisors first reported a position in TWST in Q1 2021 and has held it in 19 quarters since. 155 funds tracked by Wall St. Rank hold TWST as of Q3 2026.
- West Paces Advisors held 322 shares of Twist Bioscience worth $62.2K as of Q3 2026.
- West Paces Advisors sold 77 Twist Bioscience shares in Q3 2026, an estimated $9.5K.
- Twist Bioscience made up 0.01% of West Paces Advisors's portfolio in Q3 2026, its #265 holding.
- West Paces Advisors first reported a position in Twist Bioscience in Q1 2021 and has held it in 19 quarters since.
- 155 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.
Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.